# Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer

> **NCT02751177** · NA · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 236 (actual)

## Conditions studied

- Colorectal Cancer Metastatic

## Interventions

- **GENETIC:** KRAS, NRAS et BRAF mutation analysis from circulating plasma DNA

## Key facts

- **NCT ID:** NCT02751177
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-25
- **Primary completion:** 2017-05-30
- **Final completion:** 2017-05-30
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02751177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02751177, "Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02751177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*